Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-23 · accession 0001437749-21-020979 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-25 | 2021-08-23+ | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | $3.09 | +2,000 | 22.5K | +10% | +$6,188 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-23 | P | A | 800 | $2.95 | 21,258 | D | — | — | (F1) Holdings do not include options to purchase 42,189 shares, and do not include 4,125 restricted shares. |
| 2 | Common | Common Stock | 2021-08-25 | P | A | 1,200 | $3.19 | 22,458 | D | — | — | (F1) Holdings do not include options to purchase 42,189 shares, and do not include 4,125 restricted shares. |